Activity ID
13511Expires
December 31, 2025Format Type
EnduringCME Credit
1Fee
$0CME Provider: Clinical Care Options, LLC
Description of CME Course
In this session, participants will review the mechanism of disease of schizophrenia and hear about the potential impact of novel agents in changing the landscape of schizophrenia treatment in addressing symptom domains and adverse event profiles.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
• Analyze characteristics of emerging treatments for schizophrenia including novel mechanisms of action, kinetics, efficacy, and AEs
• Identify the role of newer and emerging agents in addressing unmet needs in the current treatment of schizophrenia
• Construct a patient care plan that integrates novel agents into the current treatment of schizophrenia
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Inpatient, Outpatient, Rural, Urban, VA/Military
